By John Schroyer, Bart Schaneman and Omar Sacirbey

A lawsuit against the U.S. government could lead to national legalization of cannabis, a judge refuses to intervene in Nevada’s recreational marijuana conflict, and High Times magazine hopes to be publicly traded.

Here’s a closer look at some notable developments in the marijuana industry over the past week.

John Schroyer  |
July 28, 2017

Could medical marijuana company’s past haunt its future?

Omar Sacirbey  | July 27, 2017

By Omar Sacirbey

Vireo Health, a multistate medical marijuana business, has aggressive expansion plans. But the Minnesota company's goals could be undermined by two former executives whom prosecutors allege moved cannabis across state lines, a violation of federal law.

There has already been fallout, and industry observers say there's potential for more.

Omar Sacirbey  |
July 27, 2017

Marijuana companies could soon face major upheaval at federal level

John Schroyer  | July 26, 2017

By John Schroyer

Life could get a lot harder for the marijuana industry in the next two months, with advocates warning that a pair of cannabis business-protecting federal policies could be in serious jeopardy.

At issue is what action the federal government may take involving the precarious 2013 Cole Memo and expiring Rohrabacher-Farr Amendment.

John Schroyer  |
July 26, 2017

By Matt Lamers

Canada's 10 provinces and three territories are in various stages of conducting public consultations that have a major impact on the regulatory framework that governs recreational marijuana in the country.

Here's how each province is approaching outreach to cannabis businesses, consumers, the general public and other stakeholders as they attempt to develop adult-use regulations.

Matt Lamers  |
July 26, 2017

By Bart Schaneman

Dr. Bronner’s has become a leading natural products company in the United States over the past three decades and a pioneering force in the hemp consumer goods space.

In 2000, Dr. Bronner’s started using hemp seed oil in its body care products, ranking as one of the first companies to do so.

Bart Schaneman  |
July 25, 2017

By Matt Lamers

Most of Canada’s provinces are soliciting input from medical cannabis companies, the public and other stakeholders to help shape the regulatory foundations of the country’s recreational marijuana industry.

The results could have a profound impact on existing and future businesses.

Matt Lamers  |
July 25, 2017